Unveiling the Relationship Between WWOX and BRCA1 in Mammary Tumorigenicity and in DNA Repair Pathway Selection

Overview

Journal Cell Death Discov

Date 2024 Mar 19

PMID 38499540

Authors

Tirza Bidany-Mizrahi

Aya Shweiki

Kian Maroun

Lina Abu-Tair

Bella Mali

Rami I Aqeilan

Affiliations

Soon will be listed here.

Abstract

Breast cancer is the leading cause of cancer-related deaths in women worldwide, with the basal-like or triple-negative breast cancer (TNBC) subtype being particularly aggressive and challenging to treat. Understanding the molecular mechanisms driving the development and progression of TNBC is essential. We previously showed that WW domain-containing oxidoreductase (WWOX) is commonly inactivated in TNBC and is implicated in the DNA damage response (DDR) through ATM and ATR activation. In this study, we investigated the interplay between WWOX and BRCA1, both frequently inactivated in TNBC, on mammary tumor development and on DNA double-strand break (DSB) repair choice. We generated and characterized a transgenic mouse model (K14-Cre;Brca1;Wwox) and observed that mice lacking both WWOX and BRCA1 developed basal-like mammary tumors and exhibited a decrease in 53BP1 foci and an increase in RAD51 foci, suggesting impaired DSB repair. We examined human TNBC cell lines harboring wild-type and mutant BRCA1 and found that WWOX expression promoted NHEJ repair in cells with wild-type BRCA1. Our findings suggest that WWOX and BRCA1 play an important role in DSB repair pathway choice in mammary epithelial cells, underscoring their functional interaction and significance in breast carcinogenesis.

References

Abu-Odeh M, Salah Z, Herbel C, Hofmann T, Aqeilan R . WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response. Proc Natl Acad Sci U S A. 2014; 111(44):E4716-25. PMC: 4226089. DOI: 10.1073/pnas.1409252111. View

Laakso M, Loman N, Borg A, Isola J . Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors. Mod Pathol. 2005; 18(10):1321-8. DOI: 10.1038/modpathol.3800456. View

Abdeen S, Salah Z, Khawaled S, Aqeilan R . Characterization of WWOX inactivation in murine mammary gland development. J Cell Physiol. 2012; 228(7):1391-6. DOI: 10.1002/jcp.24310. View

Boyle P . Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol. 2012; 23 Suppl 6:vi7-12. DOI: 10.1093/annonc/mds187. View

Xu A, Wang W, Nie J, Lui V, Hong B, Lin W . Germline mutation and aberrant transcripts of WWOX in a syndrome with multiple primary tumors. J Pathol. 2019; 249(1):19-25. DOI: 10.1002/path.5288. View

Abu-Odeh M, Hereema N, Aqeilan R . WWOX modulates the ATR-mediated DNA damage checkpoint response. Oncotarget. 2015; 7(4):4344-55. PMC: 4826209. DOI: 10.18632/oncotarget.6571. View

Shrivastav M, De Haro L, Nickoloff J . Regulation of DNA double-strand break repair pathway choice. Cell Res. 2007; 18(1):134-47. DOI: 10.1038/cr.2007.111. View

Guler G, Iliopoulos D, Guler N, Himmetoglu C, Hayran M, Huebner K . Wwox and Ap2gamma expression levels predict tamoxifen response. Clin Cancer Res. 2007; 13(20):6115-21. DOI: 10.1158/1078-0432.CCR-07-1282. View

Oster S, Aqeilan R . Programmed DNA Damage and Physiological DSBs: Mapping, Biological Significance and Perturbations in Disease States. Cells. 2020; 9(8). PMC: 7463922. DOI: 10.3390/cells9081870. View

10.

Liu C, Srihari S, Le Cao K, Chenevix-Trench G, Simpson P, Ragan M . A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy. Nucleic Acids Res. 2014; 42(10):6106-27. PMC: 4041457. DOI: 10.1093/nar/gku284. View

11.

Fan C, Oh D, Wessels L, Weigelt B, Nuyten D, Nobel A . Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006; 355(6):560-9. DOI: 10.1056/NEJMoa052933. View

12.

Xu X, Qiao W, Linke S, Cao L, Li W, Furth P . Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet. 2001; 28(3):266-71. DOI: 10.1038/90108. View

13.

Aysola K, Desai A, Welch C, Xu J, Qin Y, Reddy V . Triple Negative Breast Cancer - An Overview. Hereditary Genet. 2014; 2013(Suppl 2). PMC: 4181680. DOI: 10.4172/2161-1041.S2-001. View

14.

Wiegmans A, Al-Ejeh F, Chee N, Yap P, Gorski J, Da Silva L . Rad51 supports triple negative breast cancer metastasis. Oncotarget. 2014; 5(10):3261-72. PMC: 4102808. DOI: 10.18632/oncotarget.1923. View

15.

Jachimowicz R, Beleggia F, Isensee J, Velpula B, Goergens J, Bustos M . UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors. Cell. 2019; 176(3):505-519.e22. DOI: 10.1016/j.cell.2018.11.024. View

16.

Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A . Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet. 2001; 29(4):418-25. DOI: 10.1038/ng747. View

17.

Gomez-Cabello D, Jimeno S, Fernandez-Avila M, Huertas P . New tools to study DNA double-strand break repair pathway choice. PLoS One. 2013; 8(10):e77206. PMC: 3796453. DOI: 10.1371/journal.pone.0077206. View

18.

Taouis K, Vacher S, Guirouilh-Barbat J, Camonis J, Formstecher E, Popova T . WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer. Cancer Gene Ther. 2023; 30(8):1144-1155. PMC: 10425285. DOI: 10.1038/s41417-023-00626-x. View

19.

Jiang Y, Ji F, Liu Y, He M, Zhang Z, Yang J . Cisplatin-induced autophagy protects breast cancer cells from apoptosis by regulating yes-associated protein. Oncol Rep. 2017; 38(6):3668-3676. DOI: 10.3892/or.2017.6035. View

20.

Essers J, van Steeg H, de Wit J, Swagemakers S, Vermeij M, Hoeijmakers J . Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J. 2000; 19(7):1703-10. PMC: 310238. DOI: 10.1093/emboj/19.7.1703. View